Lorenzo Suigo

Via Luigi Mangiagalli, 25
Milan, 20133, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

FtsZ forms biomolecular condensates in a polar-growing Alphaproteobacterium.

FtsZ forms biomolecular condensates in a polar-growing Alphaproteobacterium.

Journal: mBio

Published: April 15, 2026

Mechanistic Insights into the Antimicrobial Effect of Benzodioxane-Benzamides Against Escherichia coli.

Mechanistic Insights into the Antimicrobial Effect of Benzodioxane-Benzamides Against Escherichia coli.

Journal: Antibiotics (Basel, Switzerland)

Published: December 15, 2025

Benzodioxane-benzamides targeting bacterial cell division protein FtsZ potentially disrupt SlmA-mediated nucleoid occlusion and reversible biomolecular condensation.

Benzodioxane-benzamides targeting bacterial cell division protein FtsZ potentially disrupt SlmA-mediated nucleoid occlusion and reversible biomolecular condensation.

Journal: International journal of biological macromolecules

Published: July 08, 2025

Targeting Bacterial Cell Division with Benzodioxane-Benzamide FtsZ Inhibitors as a Novel Strategy to Fight Gram-Positive Ovococcal Pathogens.

Targeting Bacterial Cell Division with Benzodioxane-Benzamide FtsZ Inhibitors as a Novel Strategy to Fight Gram-Positive Ovococcal Pathogens.

Journal: International journal of molecular sciences

Published: December 12, 2024

Benzodioxane-Benzamides as FtsZ Inhibitors: Effects of Linker's Functionalization on Gram-Positive Antimicrobial Activity.

Benzodioxane-Benzamides as FtsZ Inhibitors: Effects of Linker's Functionalization on Gram-Positive Antimicrobial Activity.

Journal: Antibiotics (Basel, Switzerland)

Published: October 10, 2023

PET Imaging of Innate Immune Activation Using 11C Radiotracers Targeting GPR84.

PET Imaging of Innate Immune Activation Using 11C Radiotracers Targeting GPR84.

Journal: JACS Au

Published: August 03, 2023

Benzodioxane-benzamides as promising inhibitors of Escherichia coli FtsZ.

Benzodioxane-benzamides as promising inhibitors of Escherichia coli FtsZ.

Journal: International journal of biological macromolecules

Published: May 23, 2023

Methylphenidate Analogues as a New Class of Potential Disease-Modifying Agents for Parkinson's Disease: Evidence from Cell Models and Alpha-Synuclein Transgenic Mice.

Methylphenidate Analogues as a New Class of Potential Disease-Modifying Agents for Parkinson's Disease: Evidence from Cell Models and Alpha-Synuclein Transgenic Mice.

Journal: Pharmaceutics

Published: May 17, 2022

Resolution via diastereomeric amides of enantiopure 1,4-benzoxathian-2- and 3-carboxylic acids and determination of their configuration.

Resolution via diastereomeric amides of enantiopure 1,4-benzoxathian-2- and 3-carboxylic acids and determination of their configuration.

Journal: Chirality

Published: March 31, 2022

Computational Design and Development of Benzodioxane-Benzamides as Potent Inhibitors of FtsZ by Exploring the Hydrophobic Subpocket.

Computational Design and Development of Benzodioxane-Benzamides as Potent Inhibitors of FtsZ by Exploring the Hydrophobic Subpocket.

Journal: Antibiotics (Basel, Switzerland)

Published: March 13, 2021

Staphylococcus aureus RnpA Inhibitors: Computational-Guided Design, Synthesis and Initial Biological Evaluation.

Staphylococcus aureus RnpA Inhibitors: Computational-Guided Design, Synthesis and Initial Biological Evaluation.

Journal: Antibiotics (Basel, Switzerland)

Published: March 12, 2021

Benzamide Derivatives Targeting the Cell Division Protein FtsZ: Modifications of the Linker and the Benzodioxane Scaffold and Their Effects on Antimicrobial Activity.

Benzamide Derivatives Targeting the Cell Division Protein FtsZ: Modifications of the Linker and the Benzodioxane Scaffold and Their Effects on Antimicrobial Activity.

Journal: Antibiotics (Basel, Switzerland)

Published: March 03, 2020

Showing 1-12 of 14

Last Updated: 09/26/2026